Hims & Hers Health, Inc. earned $0.51 per diluted share in fiscal year 2025. This represents a decrease of 3.8% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a loss of $0.83 per diluted share. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Hims & Hers Health, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Hims & Hers Health, Inc. earned $0.51 per diluted share in fiscal year 2025.
Hims & Hers Health, Inc. (HIMS) diluted earnings per share fell by 3.8% year over year, from $0.53 to $0.51 in fiscal year 2025.
Hims & Hers Health, Inc. (HIMS) reported a loss of $0.83 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 7 fiscal years this page covers, Hims & Hers Health, Inc. (HIMS) diluted earnings per share went from -$2.07 in fiscal year 2019 to $0.51 in fiscal year 2025.
Hims & Hers Health, Inc. (HIMS) reported -$0.14 in diluted earnings per share in Q3 2026. This represents a decrease of 333.3% from the same quarter a year earlier.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Hims & Hers Health, Inc. (HIMS) reported on that line in every period on record.